OCULAR THERAPEUTIX, INC (OCUL) › Cost of RevenueOCULAR THERAPEUTIX, INC (OCUL) — Cost of RevenueAnnual figures by period end, from SEC filings.2017-12-31: $457.0K2018-12-31: $465.0K2019-12-31: $2.33M2020-12-31: $2.08M2021-12-31: $4.41M2022-12-31: $4.54M2023-12-31: $5.28M2024-12-31: $5.63M2025-12-31: $6.57M$6.57M2017-12-31Cost of Revenue (USD)2025-12-31Period endedCost of RevenueChange YoYSource filing2025-12-31$6.57M+16.9%2026-02-05From 2025-01-012024-12-31$5.63M+6.5%2026-02-05From 2024-01-012023-12-31$5.28M+16.3%2026-02-05From 2023-01-012022-12-31$4.54M+3.0%2025-03-03From 2022-01-012021-12-31$4.41M+111.5%2024-03-11From 2021-01-012020-12-31$2.08M-10.4%2023-03-06From 2020-01-012019-12-31$2.33M+400.0%2022-02-28From 2019-01-012018-12-31$465.0K+1.8%2020-03-12From 2018-01-012017-12-31$457.0K—2020-03-12From 2017-01-01Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)